Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials ( ivision of Cardiology at theTufts-New ...)

HOME >> MEDICINE >> TECHNOLOGY

Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials

ivision of Cardiology at the Tufts-New England Medical Center, and professor of Medicine at Tufts University School of Medicine, Boston, Mass. Konstam presented the short- and long-term EVEREST data analyses during a late-breaker session Sunday, March 25 at the ACC. "In the long-term trial, tolvaptan neither statistically improved nor worsened survival relative to placebo. The EVEREST data suggest that tolvaptan may be a potential therapy for patients with heart failure."

Tolvaptan is a novel, investigational small molecule designed to be an antagonist of the vasopressin V2 receptor, which plays a role in the kidney's regulation of fluid excretion. The majority of patients hospitalized for ADHF, the worsening of chronic HF that affects 1 million U.S. residents annually,(3) have edema or excess body fluid, which is treated with diuretics to excrete the fluid. In contrast to diuretics, tolvaptan is designed to promote aquaresis, the excretion of electrolyte-free water.(1) Otsuka Pharmaceutical Co., Ltd. (Japan) and Otsuka Pharmaceutical Development & Commercialization, Inc., are developing tolvaptan, which has the potential to be the first available oral vasopressin receptor antagonist.(4,5)

Short-Term Studies: Pre-Specified Secondary Endpoints

In the two short-term studies, reductions in average body weight at day seven or discharge were statistically significantly different between the tolvaptan group versus the placebo group, 3.35 kilograms (kg) and 2.73 kg, respectively, in study A (p less than 0.001) and 3.77 kg and 2.79 kg, respectively, in study B (p less than 0.001). In addition, the use of tolvaptan significantly reduced patients' body weight as early as on the first day of treatment in both short-term studies (p less than 0.001).(1) There was no significant difference between the treatment groups in improvement in patient-assessed global clinical status at day 7 or discharge, if earlier; however the changes were numerically in favor
'"/>

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
2. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
3. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
4. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
7. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
8. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
9. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
10. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
11. UCB Presents Long-Term CImzia Data in Crohns Disease

Post Your Comments:

(Date:5/23/2013)... Massachusetts , May 23, 2013 ... Solutions™, announced today that the prize for ,Best Novel ... Systems and Medical Emergency Teams International Conference, hosted this ... Physicians, was awarded to a clinical research team studying ... at California Hospital in Los Angeles ...

(Date:5/23/2013)... , May 23, 2013 Omeros Corporation (NASDAQ: ... Investigational New Drug Application (IND) to evaluate OMS824 ... U.S. Food and Drug Administration (FDA). OMS824 selectively ... areas of the brain linked to a wide ... disease and schizophrenia. OMS824 has shown promising results ...

(Date:5/23/2013)... May 23, 2013 Isis Pharmaceuticals, Inc. (NASDAQ: ... that management will present a company overview at the Deutsche ... Thursday, May 30, 2013 at 8:40 a.m. ET in ... webcast of the presentation will be available on the "Investors ... . A replay will be available on the Isis Web ...

Breaking Medicine Technology:Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2 Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3 Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4 Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2 Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3 Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4 Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2

[0] Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference [0] Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease [0] Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

... Nov. 3, 2011 Prescription copay coupon marketing programs, which ... expensive brands, will increase costs by $32 billion over ... and released today by the Pharmaceutical Care Management ... "copay coupons" to undermine efforts by employers, unions and ...

... Nov. 3, 2011 Allscripts (NASDAQ: ... of Michigan , an international leader in pediatric neurology ... and ranked by U.S. News & World Report ... implement the state-of-the-art Allscripts Electronic Health Record ...

Cached Medicine Technology:Report: Brand Drug 'Copay Coupons' Raise Health Costs for Employers, Unions, and State Governments by $32 Billion 2 DMC Children's Hospital of Michigan Selects Allscripts Electronic Health Record for Employed and Affiliated Physicians 2 DMC Children's Hospital of Michigan Selects Allscripts Electronic Health Record for Employed and Affiliated Physicians 3 DMC Children's Hospital of Michigan Selects Allscripts Electronic Health Record for Employed and Affiliated Physicians 4 DMC Children's Hospital of Michigan Selects Allscripts Electronic Health Record for Employed and Affiliated Physicians 5

Report: Brand Drug 'Copay Coupons' Raise Health Costs for Employers, Unions, and State Governments by $32 Billion DMC Children's Hospital of Michigan Selects Allscripts Electronic Health Record for Employed and Affiliated Physicians

(Date:5/23/2013)... With rates of obesity at an all time high, ... to lose weight. Advances in medicine and technology now offer ... attempt to shed those extra pounds. Unfortunately the benefits of ... health consequences that often accompany them. Now a new study ... colon cancer. Diet Doc was created to offer ...

(Date:5/23/2013)... May 23, 2013 According to ... number one cause of death in America today and is ... old. More than 400,000 women die in the United States ... every minute. Seven factors are considered to profile the status ... the list. Many people are under the false assumption that ...

(Date:5/23/2013)... 2013 The Pittsburgh Riverhounds took to ... special needs children as they hosted the Watson Institute’s ... in Station Square. Approximately 100 children with special ... , In addition to the Riverhounds pro team, members ... High School Boys and Girls Varsity Soccer Teams, Point ...

(Date:5/23/2013)... Kantar Health , a leading ... CancerMPact® Biomarker Analysis , a global offer that ... oncology landscape. The analysis is based on a ... the following biomarkers: , *BRAF (melanoma) , *EGFR (non-small ... *KRAS (colorectal cancer) , *TNBC (breast cancer) , CancerMPact ...

(Date:5/23/2013)... FL (PRWEB) May 23, 2013 The ... Paddle Company reached a major milestone in its corporate ... endless manufacturing delays, the release of the Assault Hand ... paddle sports. , The Assault Hand Paddle is “revolutionizing ... paddle designed for paddle sportsmen seeking stealth and close ...

Breaking Medicine News(10 mins):Health News:hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer 2 Health News:hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer 3 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 3 Health News:Pittsburgh Riverhounds Host First-Ever Watson Institute Special Kick Clinic 2 Health News:Pittsburgh Riverhounds Host First-Ever Watson Institute Special Kick Clinic 3 Health News:Kantar Health Launches CancerMPact Biomarker Analysis 2 Health News:The Assault Hand Paddle Revolution is On 2 Health News:The Assault Hand Paddle Revolution is On 3

[0] hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients [0] Pittsburgh Riverhounds Host First-Ever Watson Institute Special Kick Clinic [0] Kantar Health Launches CancerMPact Biomarker Analysis [0] The Assault Hand Paddle Revolution is On

... A novel method which can aid in the multiplication ... harvest has been discovered.// This finding could eventually pave ... and gene therapy techniques. ,The use of ... as it is associated with less ethical concerns and ...

... small group of patients can provide an adequate representation ... health practitioners and their office practice, according to a ... ,Highly consistent and reliable data can be ... the present study in which approximately 13,000 adult patients ...

... cannabis use leading to schizophrenia has been ruled out ... advisers. The definitive link between cannabis use and impairment ... cannot be ruled out. It can lead to acute ... ,It was requested to examine fresh medical ...

... team from Northwestern University, Feinberg School of Medicine have ... found// to inhibit the production of the immune cells ... responsible for causing inflammation in brain cells leading to ... Alzheimer’s disease. ,Alzheimer’s disease is characterized by ...

... the lymph nodes also, according to a recent research, led ... immune response. // ,The dreaded disease is ... and the immature parasites travel to the animal's liver. Once ... liver cells and infect red blood cells, beginning the onset ...

... Diseases has projected alarming reports of a 32% prevalence ... The organism is implicated as a causative factor in ... prepared by the Centers for Disease Control and Prevention, ... the US. ,About 1% of the nasal ...

Cached Medicine News:Health News:Novel Technique Can Enhance Stem Cell Multiplication By 30 Fold 2 Health News:No Increased Schizophrenia Risk With Use Of Cannabis 2 Health News:Malaria Can Develop In Lymph Nodes Also 2 Health News:90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose 2

Novel Technique Can Enhance Stem Cell Multiplication By 30 Fold Data On Quality Of Health Care Can Be Easily Obtained No Increased Schizophrenia Risk With Use Of Cannabis New drug compound to treat Alzheimer’s diseas Malaria Can Develop In Lymph Nodes Also 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose

... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...

10L...

... is precision, ergonomics, and value!, ... with soft non-slip, contoured handle , ... light plunger spring action , Completely ... without the need for recalibration , ...

... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...

Medicine Products:

Finnpipette Fixed Volume, 5ul Ovation BioNatural Pipette, two-stroke, fixed volume, 10L SoftGrip 10 L Fixed Volume Pipette Eppendorf Reference Series 2000 Fixed-volume Pipette, 15 l